Veterinary Medicines

Prednisolon ad us. vet 10 mg/ml suspension for injection for cattle, horses, dogs and cats

Authorised
  • Prednisolone acetate
Download as PDF

Product identification

Medicine name:
Veyxin 10 mg/ml suspensão injetável para bovinos, equídeos, cães e gatos
Prednisolon ad us. vet 10 mg/ml suspension for injection for cattle, horses, dogs and cats
Active substance:
  • Prednisolone acetate
Target species:
  • Cattle
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Prednisolone acetate
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        35
        day
      • Milk
        24
        hour
    • Horse
      • Meat and offal
        53
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID3) 1200 millilitre(s): unspecified outer container with 12 Vial (Glass) each with 100 millilitre(s)
  • (ID2) 600 millilitre(s): unspecified outer container with 6 Vial (Glass) each with 100 millilitre(s)
  • (ID1) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1201/01/18DFVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0162/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)